Literature DB >> 1281957

Diagnostic criteria for human diffuse malignant mesothelioma.

Y Suzuki1.   

Abstract

Diffuse malignant mesothelioma is a rare tumor in the general population, yet is unique in that it is caused almost exclusively by exposure to asbestos with long-term latency (15 years and over). Pathologists are required to provide a reliable diagnosis of the tumor for clinicians who are responsible for the treatment of affected patients. Pathological diagnosis of diffuse malignant mesothelioma is not always easy; however, it has improved over the last few decades. Currently, comprehensive analysis, including gross appearance, histology, histochemistry, immunocytochemistry and electron microscopy is recommended as the best approach to an accurate diagnosis of diffuse malignant mesothelioma.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1281957     DOI: 10.1111/j.1440-1827.1992.tb01878.x

Source DB:  PubMed          Journal:  Acta Pathol Jpn        ISSN: 0001-6632


  4 in total

1.  Immunohistochemistry in the distinction between malignant mesothelioma and pulmonary adenocarcinoma: a critical evaluation of new antibodies.

Authors:  A S Abutaily; B J Addis; W R Roche
Journal:  J Clin Pathol       Date:  2002-09       Impact factor: 3.411

2.  A case report of metastasis of malignant mesothelioma to the retromolar trigone.

Authors:  A Arslan; C Ozcakir-Tomruk; E Deniz; O Akin
Journal:  World J Surg Oncol       Date:  2016-07-20       Impact factor: 2.754

Review 3.  Overview of asbestos issues in Korea.

Authors:  Hyoung Ryoul Kim
Journal:  J Korean Med Sci       Date:  2009-06-12       Impact factor: 2.153

4.  Malignant peritoneal mesothelioma with a sarcomatoid growth pattern and signet-ring-like structure in a female f344 rat.

Authors:  Aya Ohnuma-Koyama; Toshinori Yoshida; Naofumi Takahashi; Satoshi Akema; Yukiko Takeuchi-Kashimoto; Maki Kuwahara; Mika Nagaike; Kosei Inui; Nobuaki Nakashima; Takanori Harada
Journal:  J Toxicol Pathol       Date:  2013-07-10       Impact factor: 1.628

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.